| Patient | Paul Robeson |
|---|---|
| Date of birth | 1967-04-09 |
| Identifiers | MRN HR-ML048-SYN; SSN (made up) 000-48-2647 |
| Document date | 2026-03-12 |
| Author | Theodore Bankole-Ashworth, MD |
| Custodian | St. Posthumous Health Center |
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Review of results, with psychiatric consultation the same day. [S]
Mr. Robeson returns three days after his first visit and is seen by Dr. Lindqvist-Adebayo of psychiatry today. His blood tests are normal. He still wakes at three in the morning and cannot get back to sleep, has little appetite, and has spent most of the three days at home. On two of the days he again thought he would be better off dead, without any wish or plan to act; he kept to his safety plan, has put his medicines in a locked box, and has the 988 number in his phone. He has had no alcohol. He asked again who can read his record, and the protections were explained. In the structured interview with Dr. Lindqvist-Adebayo he described a first depression about two years ago, after surgery, which lifted slowly over some months without treatment. Before it he had some weeks of intense, absorbed work, sleeping his usual hours, without elation, irritability, racing thoughts or risky behavior. [S]
| Element | Detail |
|---|---|
| Symptoms | Early waking, poor appetite, low mood and withdrawal unchanged |
| Safety | Passive thoughts of death on two days; no intent or plan; medicines locked |
| Results | Blood count, metabolic panel, calcium, TSH, B12, folate, testosterone and A1c normal; HIV and syphilis tests negative |
| Consultation | Structured interview and bipolar screening with psychiatry today |
| System | Result | Finding |
|---|---|---|
| Constitutional | Positive | Exhausted; poor appetite; weight 98.8 kg |
| Psychiatric | Positive | Low mood, loss of interest, early waking, passive thoughts of death on two days; no hallucinations |
| Neurological | Negative | No headache, weakness or memory complaint |
| Genitourinary | Negative | No urinary symptoms since the prostate surgery |
4 systems reviewed. [S]
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|---|---|---|---|---|
| Sertraline 50 mg tablet, one tablet each morning | 50 mg each morning for two weeks | Oral route | 2026-03-12 to 2026-03-25 | completed | S |
| Allergy | Reaction | Status | Evidence |
|---|---|---|---|
| No known allergy | active | S |
| Date | Measure | Value | Unit | Provenance |
|---|---|---|---|---|
| 2026-03-12 | Body height | 190 | cm | S |
| 2026-03-12 | Body weight | 98.8 | kg | S |
| 2026-03-12 | Body mass index (BMI) [Ratio] | 27.4 | kg/m2 | S |
| 2026-03-12 | Systolic blood pressure | 126 | mm[Hg] | S |
| 2026-03-12 | Diastolic blood pressure | 78 | mm[Hg] | S |
| 2026-03-12 | Heart rate | 74 | /min | S |
| 2026-03-12 | Respiratory rate | 14 | /min | S |
| 2026-03-12 | Body temperature | 36.6 | Cel | S |
| 2026-03-12 | Oxygen saturation in Arterial blood by Pulse oximetry | 98 | % | S |
Vital signs recorded on 2026-03-12; see the Vital Signs section. [S]
| System | Finding |
|---|---|
| General | Tired, well groomed; weight 98.8 kg; blood pressure 126/78, pulse 74 |
| Psychiatric | Slowed speech and movement; mood 'worn through'; constricted affect; logical thought; no delusions; passive thoughts of death without intent or plan; insight good |
| Neurological | No focal signs; no tremor |
| Problem | Clinical status | Verification | Code | Provenance |
|---|---|---|---|---|
| About three months of low mood, exhaustion, poor sleep with waking at three in the morning, loss of interest in singing and reading, poor appetite with 5 kg weight loss, and withdrawal from friends, in a man of 58 under sustained political pressure; PHQ-9 22 with thoughts of being better off dead; depression suspected; medical causes being excluded and urgent psychiatric consultation arranged | resolved | confirmed | R53.83 | S — Synthetic presenting problem at intake, superseded by the diagnosis at the psychiatric consultation; anchored to his documented depression and loss of work (D). |
| Major depressive disorder, recurrent, severe, without psychotic features (second episode; structured diagnostic interview; MDQ negative and no past hypomanic or manic episode on interview) | active | confirmed | F33.2 | S — Synthetic modern diagnosis anchored to his documented depression after the 1955 breakdown (D); the bipolar interpretation (R) is addressed and not adopted. |
| Sustained political persecution: passport withheld, concerts and recordings cancelled, income lost, and surveillance by federal agencies; a major and realistic stressor, not a delusion | active | confirmed | Z60.5 | S — Synthetic coding of his documented persecution as a social determinant of his depression. |
Protocol monitoring: items the monitoring protocol calls for at this visit. [S]
| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Survey | PHQ-9 | Baseline and at least monthly during acute treatment (CMID) | Up to date | 22 three days ago, item 9 scored 1 |
| Survey | Structured diagnostic interview | At diagnosis | Completed today | Second major depressive episode, severe, without psychotic features; no past hypomania or mania |
| Survey | Mood Disorder Questionnaire (MDQ) | Once at the initial depression workup (CMID) | Completed today | 5 of 13 items, not in one period and without serious problems: negative |
| Survey | Suicide-risk review (C-SSRS screen since the last visit), safety plan, locked medicines and the 988 Suicide & Crisis Lifeline | Every visit during active treatment | Completed today | Passive thoughts of death on two days; no intent, plan or preparation; medicines locked; 988 in his phone |
| Laboratory | Tests for medical causes of depression | At diagnosis | Up to date | Blood count, metabolic panel, calcium, TSH, B12, folate, morning testosterone and A1c normal three days ago; HIV and syphilis tests negative |
| Survey | Cognitive screen (MoCA) | Baseline, and before and during any course of ECT | Up to date | MoCA 28 three days ago |
| Medication safety | Start of sertraline | At the start, at two weeks and with each dose change | Completed today | 50 mg from today; nausea, sleep change and sexual side effects explained; nurse phone check in two weeks before the increase |
| Laboratory | Sodium (SSRI or SNRI in an older adult) | Baseline, about four to six weeks after starting, and with symptoms | Up to date | 140 mmol/L at baseline; next at six weeks |
| Medication safety | Watch for hypomania or mixed features after starting or changing an antidepressant | Every visit; repeat the MDQ if features emerge | Completed today | Explained what to watch for; none at baseline |
| Referral | Behavioral activation with a psychologist | Weekly for about sixteen sessions | Ordered | First session next week with a psychologist he chose |
| Self-management | Trust, confidentiality and culturally responsive care | Every visit | Completed today | Record protections explained; his account of surveillance recorded as realistic; a therapist of his choosing |
| Referral | Social work for income and costs | At diagnosis and as needed | Referred | First meeting with the social worker next week |
| Referral | Psychiatric consultation | Within days for severe depression with thoughts of death | Completed today | Seen today by Dr. Lindqvist-Adebayo |
Goal progress:
Guideline basis: APA Clinical Practice Guideline for the Treatment of Depression Across Three Age Cohorts (2019); VA/DoD Clinical Practice Guideline for the Management of Major Depressive Disorder (2022); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024); CMID: Clinical Monitoring Intelligence Database, depression, bipolar, and mood disorders monograph (2026); Williams DR, et al. Prevalence and distribution of major depressive disorder in African Americans, Caribbean blacks, and non-Hispanic whites: results from the National Survey of American Life. Arch Gen Psychiatry 2007;64(3):305-315 (2007); Racial disparities in psychotic disorder diagnosis: A review of empirical literature (2014)
Follow-up: Nurse phone call in two weeks before the sertraline increase. Six-week review with the PHQ-9 and sodium. Weekly behavioral activation. Call or text 988 at any time in a crisis. Next scheduled visit 2026-04-20: six-week review: minimal response; sertraline increased. [S]